The MHC-class II genes are indeed the driving genetic factor for CeD, but there are numerous non-MHC genes that can increase the risk for CeD, which are primarily located in non-coding regions [16,17]. The gene discussed is HLA-C; the disease is cranioectodermal dysplasia.